Nephrology And Transplant Medi is categorized under Health Services in Washington, DC and active since 2012.
Nephrology And Transplant Medi was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Joyce Gonin at the company’s single location by writing to 4910 Mass Avenue Nw # 301, Washington, District of Columbia DC 20016 or by phoning (410) 971-0081. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nephrology And Transplant Medi |
| Contact Person: | Joyce Gonin |
| Address: | 4910 Mass Avenue Nw # 301, Washington, District of Columbia 20016 |
| Phone Number: | (410) 971-0081 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Nephrology And Transplant Medi was started in 2012 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Joyce Gonin for inquiries that concern Nephrology And Transplant Medi by calling the company number (410) 971-0081, as your correspondence is most welcome. Additionally, the physical location of the single location of Nephrology And Transplant Medi can be found at the coordinates 38.945789,-77.09678 as well as the street address 4910 Mass Avenue Nw # 301 in Washington, District of Columbia 20016.
For its online presence, you may visit Nephrology And Transplant Medi’s website at and engage with its social media outlets through on Twitter and on Facebook.